These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 1241167

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. STUDIES ON HYDROLYSIS OF CARDIOLIPIN BY SNAKE VENOM PHOSPHOLIPASE A.
    OKUYAMA H, NOJIMA S.
    J Biochem; 1965 Apr; 57():529-38. PubMed ID: 14318082
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Synthesis of cell-impermeable inhibitor of phospholipase A2.
    Yedgar S, Reisfeld N, Dagan A.
    FEBS Lett; 1986 May 05; 200(1):165-8. PubMed ID: 2422059
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment.
    Waghmare AB, Salvi NC, Deopurkar RL, Shenoy PA, Sonpetkar JM.
    Toxicon; 2014 May 05; 82():83-92. PubMed ID: 24582735
    [Abstract] [Full Text] [Related]

  • 28. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS, Wanas S, Helmy MH, Hashem M.
    J Nat Toxins; 2002 Dec 05; 11(4):329-35. PubMed ID: 12503876
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Linear B-cell epitopes in BthTX-1, BthTX-II and BthA-1, phospholipase A₂'s from Bothrops jararacussu snake venom, recognized by therapeutically neutralizing commercial horse antivenom.
    De-Simone SG, Napoleão-Pego P, Teixeira-Pinto LA, Santos JD, De-Simone TS, Melgarejo AR, Aguiar AS, Marchi-Salvador DP.
    Toxicon; 2013 Sep 05; 72():90-101. PubMed ID: 23792452
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Intraspecific differences in the immunochemical reactivity and neutralization of venom from Argentinean Bothrops (Rhinocerophis) alternatus by specific experimental antivenoms.
    Lanari LC, Alagón A, Costa de Oliveira V, Laskowicz RD, Boyer L, Lago NR, Alejandro A, de Roodt AR.
    Toxicon; 2014 Jul 05; 85():31-45. PubMed ID: 24769139
    [Abstract] [Full Text] [Related]

  • 35. Phospholipase A2 activity and substrate specificity of snake venom presynaptic toxins.
    Napias C, Heilbronn E.
    Biochemistry; 1980 Mar 18; 19(6):1146-51. PubMed ID: 7370229
    [Abstract] [Full Text] [Related]

  • 36. Anticoagulant activity and plasma phosphatidylserine hydrolysis by snake venom phospholipases A2.
    Condrea E, Yang CC, Rosenberg P.
    Thromb Haemost; 1983 Apr 28; 49(2):151. PubMed ID: 6868012
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Characterization of crystals of two venom phospholipases A2.
    Pasek M, Keith C, Feldman D, Sigler PB.
    J Mol Biol; 1975 Sep 25; 97(3):395-7. PubMed ID: 1181469
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.